Dual inhibition of Jak2 and STAT5 enhances killing of myeloproliferative neoplasia cells

被引：32
|
作者：
Bar-Natan, M. [1 ,2 ,3 ]
Nelson, E. A. [1 ]
Walker, S. R. [1 ]
Kuang, Y. [4 ]
Distel, R. J. [4 ]
Frank, D. A. [1 ,2 ,3 ]
机构：
[1] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Ctr Clin & Translat Res, Translat Res Lab, Boston, MA 02115 USA
来源：
LEUKEMIA | 2012年 / 26卷 / 06期
关键词：
MYELOFIBROSIS; EXPRESSION; DISORDERS; JAK2V617F;
D O I：
10.1038/leu.2011.338
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：1407 / 1410
页数：5
相关论文
共 50 条
  • [31] Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
    L Schafranek
    E Nievergall
    J A Powell
    D K Hiwase
    T Leclercq
    T P Hughes
    D L White
    Leukemia, 2015, 29 : 76 - 85
  • [32] Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
    Schafranek, L.
    Nievergall, E.
    Powell, J. A.
    Hiwase, D. K.
    Leclercq, T.
    Hughes, T. P.
    White, D. L.
    LEUKEMIA, 2015, 29 (01) : 76 - 85
  • [33] Pyrvinium selectively induces apoptosis of lymphoma cells through impairing mitochondrial functions and JAK2/STAT5
    Xiao, Meifang
    Zhang, Liming
    Zhou, Yizheng
    Rajoria, Pasupati
    Wang, Changfu
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 469 (03) : 716 - 722
  • [34] JAK2/STAT5 inhibition protects mice from experimental autoimmune encephalomyelitis by modulating T cell polarization
    Wei, Yingying
    Braunstein, Zachary
    Chen, Jun
    Min, Xinwen
    Yang, Handong
    Duan, Lihua
    Dong, Lingli
    Zhong, Jixin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 120
  • [35] Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells
    Qian, Linxi
    Lopez, Veronica
    Seo, Young Ah
    Kelleher, Shannon L.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2009, 297 (02): : C369 - C377
  • [36] Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
    Brkic, Sime
    Stivala, Simona
    Santopolo, Alice
    Szybinski, Jakub
    Jungius, Sarah
    Passweg, Jakob R.
    Tsakiris, Dimitrios
    Dirnhofer, Stefan
    Hutter, Gregor
    Leonards, Katharina
    Lischer, Heidi E. L.
    Dettmer, Matthias S.
    Neel, Benjamin G.
    Levine, Ross L.
    Meyer, Sara C.
    LEUKEMIA, 2021, 35 (10) : 2875 - 2884
  • [37] Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy
    Sime Brkic
    Simona Stivala
    Alice Santopolo
    Jakub Szybinski
    Sarah Jungius
    Jakob R. Passweg
    Dimitrios Tsakiris
    Stefan Dirnhofer
    Gregor Hutter
    Katharina Leonards
    Heidi E. L. Lischer
    Matthias S. Dettmer
    Benjamin G. Neel
    Ross L. Levine
    Sara C. Meyer
    Leukemia, 2021, 35 : 2875 - 2884
  • [38] SHP2 Inhibition Enhances JAK2 Inhibitor Therapy in Preclinical Models of Myeloproliferative Neoplasms
    Pandey, Garima
    Mazzacurati, Lucia
    Horvat, Nathan P.
    Rowsell, Tegan
    Amin, Narmin E.
    Zhang, Guolin
    Akuffo, Afua Adutwumwa
    Colin-Leitzinger, Christelle M.
    Haura, Eric B.
    Kuykendall, Andrew T.
    Epling-Burnette, P. K.
    Reuther, Gary W.
    BLOOD, 2023, 142
  • [39] Inhibition of DNA methyltransferase induces G2 cell cycle arrest and apoptosis in human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5 signalling
    Xiong, Hua
    Chen, Zhao-Fei
    Liang, Qin-Chuan
    Du, Wan
    Chen, Hui-Min
    Su, Wen-Yu
    Chen, Guo-Qiang
    Han, Ze-Guang
    Fang, Jing-Yuan
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2009, 13 (9B) : 3668 - 3679
  • [40] AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells
    Pearson, Stella
    Blance, Rognvald
    Somervaille, Tim C. P.
    Whetton, Anthony D.
    Pierce, Andrew
    HEMASPHERE, 2019, 3 (03):
12345